Last reviewed · How we verify

NCT05100147

Uterine Closure Techniques and Cesarean Scar Defect Risk

Completed NA Last updated 31 October 2023
What this trial tests

NA trial testing Uterine closure during Cesarean section in Cesarean Section Complications in 43 participants. Completed in 31 May 2022.

Timeline
1 November 2021
Primary endpoint
31 May 2022
31 May 2022

Quick facts

Lead sponsorMersin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment43
Start date1 November 2021
Primary completion31 May 2022
Estimated completion31 May 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

Adults 18 to 40, female only, with Cesarean Section Complications or Scar; Deformity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cesarean operations are one of the most common obsetric operations and have an increasing trend in all over the world. However unfortunately the operation techniques have not been standardized yet. It is well known that different uterine closure techniques result in differences with respect to wound healing on the uterus; however, the ideal uterine closure technique is yet not known. The aim of this study is to assess the results of different uterine closure techniques during cesarean section with respect to the development of cesarean scar defects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05100147.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing